Published Date: 19 Sep 2025
A new study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise ...
Read Full NewsDuring the COVID-19 pandemic, Medicaid expansion was associated with smaller declines in early-stage cancer detection, according to a study published online Oct. 21 in the Journal of the National Cancer Institute.
What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood cancer—while helping avoid toxic or potentially unnecessary treatments?
1.
Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.
2.
the contribution of cortactin to the development of cancer.
3.
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
4.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
5.
In inflammatory breast cancer, ER beta regulates estrogen signaling.
1.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
2.
Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025
3.
Unlocking the Potential of Palbociclib: A Comprehensive Overview
4.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
5.
Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation